On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer ...

TNF inhibitors for the treatment of axial spondyloarthritis may decrease the risk for hip or spine fracture by as much as 29% ...

If you choose medication therapy for post-traumatic stress disorder (PTSD), experts generally recommend selective serotonin ...

Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Results of a database review revealed duloxetine, pregabalin, and milnacipran as the only effective pharmacological therapies for managing pain in fibromyalgia.

EMS machines are a popular option for managing PAD – but a vascular surgeon explains why they should be a supplement to ...

To manage the daily pain, frequent brain fog, and sporadic days of full-body exhaustion, my primary care doctor suggested a ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Right now, the FDA has approved the new drug to treat pain from an injury or surgery. Its manufacturer is also testing it for ...